Huifeng Biosciences

Huifeng Bio-pharmaceutical is a prominent life sciences company based in China that specializes in the research, development, and large-scale production of plant-derived active pharmaceutical ingredients (APIs). The company is recognized as a global leader in the production of Rutin and its derivatives, including Quercetin and Troxerutin, which are essential for treating various vascular and inflammatory conditions. Beyond flavonoids, Huifeng produces high-quality L-Dopa, a critical component in the management of Parkinson's disease. Their operations are supported by advanced extraction and semi-synthesis technologies within GMP-certified facilities. Huifeng serves a diverse international market, providing raw materials for the pharmaceutical, health supplement, and cosmetic sectors. The company's commitment to quality and sustainable sourcing has established it as a key supplier in the global bio-pharmaceutical supply chain.